BCL2 and neoplasm: sNK cells have shown enhanced survival in the tumor microenvironment (TME) due to elevated levels of anti-apoptotic proteins like BCL2 and reduced levels of pro-apoptotic proteins, enabling them to resist tumor-induced cell death [63].